Подобно на бързодействащите инсулинови аналози, инхалаторният човешки инсулин има по - н
Inhaled human insulin has a duration of glucose lowering activity comparable to subcutaneously administered fast-acting human insulin and longer than fast-acting insulin analogues (see Figure 1).